To confirm the impact of inflammasome activation on stroke outcomes, blood samples from 26 stroke patients and 40 sex- and age-matched healthy controls (Table 1) were collected and inflammasome markers NLRP3 and IL-1β were analyzed. This evidence concerns the gene NLRP3 and stroke disorder.